tiprankstipranks
Advertisement
Advertisement
Acumen announces new research findings at Alzheimer’s and Parkinson’s conference
PremiumThe FlyAcumen announces new research findings at Alzheimer’s and Parkinson’s conference
14d ago
Maintaining Buy on Acumen (ABOS): EBD-Enabled Alzheimer’s Pipeline, Extended Runway, and Discounted Valuation Ahead of ALTITUDE-AD Readout
Premium
Ratings
Maintaining Buy on Acumen (ABOS): EBD-Enabled Alzheimer’s Pipeline, Extended Runway, and Discounted Valuation Ahead of ALTITUDE-AD Readout
14d ago
Acumen Pharma: Differentiated Alzheimer’s Oligomer Antibody and BBB‑Shuttle Platform Support Buy Rating and Higher $8 Target
Premium
Ratings
Acumen Pharma: Differentiated Alzheimer’s Oligomer Antibody and BBB‑Shuttle Platform Support Buy Rating and Higher $8 Target
14d ago
Analysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks
PremiumStock Analysis & IdeasAnalysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks
2M ago
Acumen Updates Investor Presentation, Highlights 2026 Alzheimer’s Milestones
Premium
Company Announcements
Acumen Updates Investor Presentation, Highlights 2026 Alzheimer’s Milestones
3M ago
Acumen initiated with a Buy at Lucid Capital
Premium
The Fly
Acumen initiated with a Buy at Lucid Capital
3M ago
Acumen Pharmaceuticals’ Earnings Call: Progress and Challenges
PremiumCompany AnnouncementsAcumen Pharmaceuticals’ Earnings Call: Progress and Challenges
5M ago
Acumen Pharmaceuticals Reports Q3 Financial Results
Premium
Company Announcements
Acumen Pharmaceuticals Reports Q3 Financial Results
5M ago
Acumen reports Q3 EPS (44c), consensus (68c)
Premium
The Fly
Acumen reports Q3 EPS (44c), consensus (68c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100